Emile Voest

Emile Voest

More and more cancer drugs are only suitable for a small group of patients. However, we are often not capable to find these patients. That is why every patient with metastatic cancer should be genetically screened before starting treatment.

Back to news

More news

New study using Hartwig Medical Foundation data maps how breast cancer’s genetic makeup shifts when it spreads

New study using Hartwig Medical Foundation data maps how breast cancer’s genetic makeup shifts when it spreads

16-07-2026

Analysis of nearly 1,300 tumor genomes across ten genomic subtypes points to candidate drug targets and biomarkers for metastatic breast …

GLOW: working toward more treatment options for glioblastoma

GLOW: working toward more treatment options for glioblastoma

23-05-2023

The outlook for patients with glioblastoma has been unfavorable for years, and treatment options remain limited. That is a reason …

The value of the GENAYA project for patients of the future 

The value of the GENAYA project for patients of the future 

09-04-2026

The GENAYA project has been extended through 2028. A total of 39 hospitals now participate in the project, which is led by …

Would you like to be kept up to date with new developments?

Sign up for our newsletters

Want to know more about the complete DNA test?

Visit OncoAct.nl